Goldman Sachs Group Toekomstige groei

Future criteriumcontroles 1/6

Goldman Sachs Group zal naar verwachting groeien in winst en omzet met respectievelijk 10.6% en 5.8% per jaar. De winst per aandeel zal naar verwachting groeien met 13.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.1% zijn.

Belangrijke informatie

10.6%

Groei van de winst

13.9%

Groei van de winst per aandeel

Capital Markets winstgroei	13.8%
Inkomstengroei	5.8%
Toekomstig rendement op eigen vermogen	13.1%
Dekking van analisten	Good
Laatst bijgewerkt	05 Nov 2024

Recente toekomstige groei-updates

The Goldman Sachs Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Nov 07

Results: The Goldman Sachs Group, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Oct 18

Recent updates

The Goldman Sachs Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Nov 07

Morgan Stanley Vs. Goldman Sachs: Better Fixed Income Investment?

Oct 18

Results: The Goldman Sachs Group, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Oct 18

Goldman Sachs Group's (NYSE:GS) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Goldman Sachs: Favorable Fundamentals Are Reflected In Valuation (Downgrade)

Aug 20

Goldman Sachs Group (NYSE:GS) Has Announced That It Will Be Increasing Its Dividend To $3.00

Aug 12

Goldman Sachs Group's (NYSE:GS) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 22

Goldman Sachs: Q2 Earnings Show Growth Is On The Horizon

Jul 18

Goldman Sachs Q2 Preview: Accelerating EPS Growth (Rating Upgrade)

Jul 10

Goldman Sachs Is Reinventing Itself: A Strategic Shift Ignites Growth

Jul 04

Goldman Sachs: Too Late To Buy

May 29

Winst- en omzetgroeiprognoses

NYSE:GS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	56,707	14,647	N/A	N/A	13
12/31/2025	54,559	13,573	N/A	N/A	15
12/31/2024	51,743	12,273	N/A	N/A	14
9/30/2024	49,387	11,419	-90,387	-88,336	N/A
6/30/2024	48,895	10,520	-77,902	-75,810	N/A
3/31/2024	46,726	8,700	-52,245	-50,029	N/A
12/31/2023	45,226	7,856	-14,903	-12,587	N/A
9/30/2023	44,106	7,170	-19,915	-17,391	N/A
6/30/2023	43,756	8,246	21,146	24,153	N/A
3/31/2023	44,673	9,968	34,254	37,646	N/A
12/31/2022	44,650	10,711	4,960	8,708	N/A
9/30/2022	47,324	13,339	68,031	72,144	N/A
6/30/2022	49,297	15,668	12,868	16,874	N/A
3/31/2022	53,580	18,232	-12,361	-8,053	N/A
12/31/2021	58,982	21,116	1,631	6,298	N/A
9/30/2021	58,135	21,675	-12,913	-7,962	N/A
6/30/2021	55,205	19,631	61,168	66,234	N/A
3/31/2021	51,430	14,478	29,342	34,120	N/A
12/31/2020	41,462	8,890	-24,844	-18,535	N/A
9/30/2020	39,633	6,245	13,137	20,089	N/A
6/30/2020	37,162	4,802	-13,256	-5,073	N/A
3/31/2020	34,704	6,809	6,047	15,205	N/A
12/31/2019	35,481	7,871	15,425	23,868	N/A
9/30/2019	33,720	8,476	-20,151	-11,719	N/A
6/30/2019	34,334	9,139	-35,206	-26,807	N/A
3/31/2019	34,489	9,286	-35,387	-26,840	N/A
12/31/2018	35,942	9,841	8,582	16,564	N/A
9/30/2018	35,918	5,376	-11,445	-4,523	N/A
6/30/2018	35,598	4,954	N/A	3,504	N/A
3/31/2018	34,083	4,236	N/A	-15,802	N/A
12/31/2017	32,073	3,661	N/A	-20,489	N/A
9/30/2017	32,409	7,953	N/A	-7,449	N/A
6/30/2017	32,251	8,022	N/A	-14,739	N/A
3/31/2017	32,296	8,033	N/A	6,053	N/A
12/31/2016	30,608	7,066	N/A	6,494	N/A
9/30/2016	29,711	5,491	N/A	10,669	N/A
6/30/2016	28,404	4,721	N/A	16,516	N/A
3/31/2016	29,541	3,994	N/A	-1,408	N/A
12/31/2015	33,820	5,546	N/A	9,481	N/A
9/30/2015	34,235	7,003	N/A	5,134	N/A
6/30/2015	35,761	7,816	N/A	-5,035	N/A
3/31/2015	35,817	8,853	N/A	3,334	N/A
12/31/2014	34,528	8,054	N/A	-7,932	N/A
9/30/2014	35,622	8,270	N/A	-10,311	N/A
6/30/2014	33,957	7,555	N/A	-4,783	N/A
3/31/2014	33,444	7,467	N/A	6,020	N/A
12/31/2013	34,206	7,702	N/A	4,543	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei GS ( 10.6% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van GS ( 10.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).

Hoge groeiwinsten: De winst van GS zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van GS ( 5.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van GS ( 5.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen GS zal naar verwachting over 3 jaar laag zijn ( 13.1 %).

Goldman Sachs Group Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

The Goldman Sachs Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Results: The Goldman Sachs Group, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

The Goldman Sachs Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Now 21% undervalued

Insider recently sold US$2.1m worth of stock

Morgan Stanley Vs. Goldman Sachs: Better Fixed Income Investment?

Results: The Goldman Sachs Group, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Goldman Sachs: Growth Signs In Key Segments Drive Confidence (Rating Upgrade)

Goldman Sachs Appoints Michael Tarulli as Partner and Global Head for Aerospace and Defence

The Goldman Sachs Group, Inc. (NYSE:GS) Doing What It Can To Lift Shares

Goldman Sachs Is A Buy Amid Favorable Environment, Attractive Valuation

Goldman Sachs Announces Executive Changes

Boston Scientific Corporation (NYSE:BSX) completed the acquisition of Silk Road Medical, Inc (NasdaqGS:SILK) from a group of shareholders.

Goldman Sachs Hires Melissa Goldman as Partner and Global Head of Technology Engineering for Its Global Banking and Markets Division

The Goldman Sachs Group, Inc. to Report Q3, 2025 Results on Oct 15, 2025

Goldman Sachs Group's (NYSE:GS) Upcoming Dividend Will Be Larger Than Last Year's

Upcoming dividend of US$3.00 per share

Goldman Sachs: Favorable Fundamentals Are Reflected In Valuation (Downgrade)

Chairman & CEO recently sold US$3.0m worth of stock

Bolt Threads Inc. completed the acquisition of Golden Arrow Merger Corp. (NasdaqCM:GAMC) from Golden Arrow Sponsor, LLC, Fir Tree Capital Management LP, Magnetar Financial LLC, The Goldman Sachs Group, Jane Street Group, LLC and others.

Goldman Sachs Group (NYSE:GS) Has Announced That It Will Be Increasing Its Dividend To $3.00

Goldman Sachs Appoints Bryan Jacobi as Executive to Its Asset Management Arm

Now 21% undervalued

The Goldman Sachs Group, Inc. Announces Management Appointments

Goldman Sachs Group's (NYSE:GS) Shareholders Will Receive A Bigger Dividend Than Last Year

Independent Director recently sold US$5.1m worth of stock

Independent Director notifies of intention to sell stock

Goldman Sachs: Q2 Earnings Show Growth Is On The Horizon

Second quarter dividend increased to US$3.00

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Goldman Sachs Q2 Preview: Accelerating EPS Growth (Rating Upgrade)

The Goldman Sachs Group, Inc. (NYSE:GS) agreed to acquire an unknown majority stake in Tait Towers Inc. from Providence Equity Partners L.L.C.

The Goldman Sachs Group, Inc. (NYSE:GS) agreed to acquire an unknown majority stake in Tait Towers Inc. from Providence Equity Partners L.L.C.

Goldman Sachs Is Reinventing Itself: A Strategic Shift Ignites Growth

Now 16% undervalued

Now 16% undervalued

Now 16% undervalued

Saudi Tadawul Group Holding Company (SASE:1111) completed the acquisition of unknown minority stake in Dubai Mercantile Exchange Limited from a group of sellers.

Now 20% undervalued

The Goldman Sachs Group, Inc. Appoints John B. Hess as Independent Director of the Board, Effective June 24, 2024

Now 20% undervalued

Goldman Sachs: Too Late To Buy

The Goldman Sachs Group, Inc. (NYSE:GS) acquired Xpress Wellness Urgent Care from Latticework Capital Management.

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven